Literature DB >> 31672265

Large in-frame 5' deletions in DMD associated with mild Duchenne muscular dystrophy: Two case reports and a review of the literature.

Elizabeth M Gibbs1, Florian Barthélémy2, Emilie D Douine3, Natalie C Hardiman2, Perry B Shieh4, Negar Khanlou5, Rachelle H Crosbie6, Stanley F Nelson7, M Carrie Miceli8.   

Abstract

Duchenne muscular dystrophy is caused by mutations in the dystrophin-encoding DMD gene. While Duchenne is most commonly caused by large intragenic deletions that cause frameshift and complete loss of dystrophin expression, in-frame deletions in DMD can result in the expression of internally truncated dystrophin proteins and may be associated with a milder phenotype. In this study, we describe two individuals with large in-frame 5' deletions (exon 3-23 and exon 3-28) that remove the majority of the N-terminal region, including part of the actin binding and central rod domains. Both patients had progressive muscle weakness during childhood but are observed to have a relatively mild disease course compared to typical Duchenne. We show that in muscle biopsies from both patients, truncated dystrophin is expressed at the sarcolemma. We have additionally developed a patient-specific fibroblast-derived cell model, which can be inducibly reprogrammed to form myotubes that largely recapitulate biopsy findings for the patient with the exon 3-23 deletion, providing a culture model for future investigation of this unusual case. We discuss these mutations in the context of previously reported 5' in-frame DMD deletions and relevant animal models, and review the spectrum of phenotypes associated with these deletions.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Becker muscular dystrophy; Duchenne muscular dystrophy; Dystrophin; Dystrophin-glycoprotein complex; Utrophin

Mesh:

Substances:

Year:  2019        PMID: 31672265      PMCID: PMC7092699          DOI: 10.1016/j.nmd.2019.09.009

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  38 in total

Review 1.  Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule.

Authors:  Annemieke Aartsma-Rus; Judith C T Van Deutekom; Ivo F Fokkema; Gert-Jan B Van Ommen; Johan T Den Dunnen
Journal:  Muscle Nerve       Date:  2006-08       Impact factor: 3.217

2.  Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy.

Authors:  S B Malhotra; K A Hart; H J Klamut; N S Thomas; S E Bodrug; A H Burghes; M Bobrow; P S Harper; M W Thompson; P N Ray
Journal:  Science       Date:  1988-11-04       Impact factor: 47.728

3.  Validation and Detection of Exon Skipping Boosters in DMD Patient Cell Models and mdx Mouse.

Authors:  Florian Barthelemy; Dereck Wang; Stanley F Nelson; M Carrie Miceli
Journal:  Methods Mol Biol       Date:  2018

4.  Functional correction of dystrophin actin binding domain mutations by genome editing.

Authors:  Viktoriia Kyrychenko; Sergii Kyrychenko; Malte Tiburcy; John M Shelton; Chengzu Long; Jay W Schneider; Wolfram-Hubertus Zimmermann; Rhonda Bassel-Duby; Eric N Olson
Journal:  JCI Insight       Date:  2017-09-21

5.  Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family.

Authors:  I B Ginjaar; A L Kneppers; J D v d Meulen; L V Anderson; M Bremmer-Bout; J C van Deutekom; J Weegenaar; J T den Dunnen; E Bakker
Journal:  Eur J Hum Genet       Date:  2000-10       Impact factor: 4.246

6.  Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex and partially prevents dystrophy.

Authors:  Laura E Warner; Christiana DelloRusso; Robert W Crawford; Inna N Rybakova; Jitandrakumar R Patel; James M Ervasti; Jeffrey S Chamberlain
Journal:  Hum Mol Genet       Date:  2002-05-01       Impact factor: 6.150

7.  MLPA analysis of an Argentine cohort of patients with dystrophinopathy: Association of intron breakpoints hot spots with STR abundance in DMD gene.

Authors:  Leonela N Luce; Viviana Dalamon; Marcela Ferrer; Diana Parma; Irene Szijan; Florencia Giliberto
Journal:  J Neurol Sci       Date:  2016-04-02       Impact factor: 3.181

8.  Functional capacity of dystrophins carrying deletions in the N-terminal actin-binding domain.

Authors:  Glen B Banks; Paul Gregorevic; James M Allen; Eric E Finn; Jeffrey S Chamberlain
Journal:  Hum Mol Genet       Date:  2007-06-22       Impact factor: 6.150

9.  Exon 32 Skipping of Dysferlin Rescues Membrane Repair in Patients' Cells.

Authors:  Florian Barthélémy; Cédric Blouin; Nicolas Wein; Vincent Mouly; Sébastien Courrier; Eugénie Dionnet; Virginie Kergourlay; Yves Mathieu; Luis Garcia; Gillian Butler-Browne; Christophe Lamaze; Nicolas Lévy; Martin Krahn; Marc Bartoli
Journal:  J Neuromuscul Dis       Date:  2015-09-02

10.  DMD genotype correlations from the Duchenne Registry: Endogenous exon skipping is a factor in prolonged ambulation for individuals with a defined mutation subtype.

Authors:  Richard T Wang; Florian Barthelemy; Ann S Martin; Emilie D Douine; Ascia Eskin; Ann Lucas; Jenifer Lavigne; Holly Peay; Negar Khanlou; Lee Sweeney; Rita M Cantor; M Carrie Miceli; Stanley F Nelson
Journal:  Hum Mutat       Date:  2018-07-12       Impact factor: 4.700

View more
  2 in total

1.  Genotype-Phenotype Correlations in Duchenne and Becker Muscular Dystrophy Patients from the Canadian Neuromuscular Disease Registry.

Authors:  Kenji Rowel Q Lim; Quynh Nguyen; Toshifumi Yokota
Journal:  J Pers Med       Date:  2020-11-23

2.  Modeling Patient-Specific Muscular Dystrophy Phenotypes and Therapeutic Responses in Reprogrammed Myotubes Engineered on Micromolded Gelatin Hydrogels.

Authors:  Florian Barthélémy; Jeffrey W Santoso; Laura Rabichow; Rongcheng Jin; Isaiah Little; Stanley F Nelson; Megan L McCain; M Carrie Miceli
Journal:  Front Cell Dev Biol       Date:  2022-04-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.